Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration

The application of autologous mesenchymal stem cells (MSC) for the treatment of bone defects requires two invasive procedures and several weeks of ex vivo cell expansion. To overcome these limitations, the administration of allogeneic MSC may be attractive, because they are anticipated to be immunop...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapp, Anna E., Bindl, Ronny, Erbacher, Annika, Kruchen, Anne, Rojewski, Markus, Schrezenmeier, Hubert, Müller, Ingo, Ignatius, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163925/
https://www.ncbi.nlm.nih.gov/pubmed/30149650
http://dx.doi.org/10.3390/ijms19092526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163925/
https://www.ncbi.nlm.nih.gov/pubmed/30149650
http://dx.doi.org/10.3390/ijms19092526

Ejemplares similares